Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

NCT03913182 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma
Apatinib
Recurrence
Metastasis

Interventions

DRUG: apatinib

Sponsor

Shanghai Chest Hospital